Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials
Trkulja, V. & Kolundžić, R. (2010). Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials. Croatian Medical Journal, 51. (2), 113-123. doi: 10.3325/cmj.2010.51.113
Trkulja, Vladimir and Robert Kolundžić. "Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials." Croatian Medical Journal, vol. 51, no. 2, 2010, pp. 113-123. https://doi.org/10.3325/cmj.2010.51.113
Trkulja, Vladimir and Robert Kolundžić. "Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials." Croatian Medical Journal 51, no. 2 (2010): 113-123. https://doi.org/10.3325/cmj.2010.51.113
Trkulja, V. and Kolundžić, R. (2010) 'Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials', Croatian Medical Journal, 51(2), pp. 113-123. doi: 10.3325/cmj.2010.51.113
Trkulja V, Kolundžić R. Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials. Croatian Medical Journal [Internet]. 2010 April 15 [cited 2024 August 20];51(2):113-123. doi: 10.3325/cmj.2010.51.113
V. Trkulja and R. Kolundžić, "Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials", Croatian Medical Journal, vol. 51, no. 2, pp. 113-123, April 2010. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:728787. [Accessed: 20 August 2024]